Notice of Intent - EMIT II Plus Amphetamine Assay 1L Sole-Source

Special NoticeNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in JBSA LACKLAND, TX
  • Industry: In-Vitro Diagnostic Substance Manufacturing

Contract Details

Notice ID
FA301626Q0096
Opportunity Type
Special Notice
Sub-Agency
DEPT OF THE AIR FORCE
Office
FA3016 502 CONS CL
Posted Date
Friday, July 10, 2026
Response Deadline
Monday, July 20, 2026
PSC Code
6550
Set-Aside
No Set Aside
Place of Performance
JBSA LACKLAND, TX, 78236-5286
Status
Active

Description

The 502d Contracting Squadron, Joint Base San Antonio-Lackland (JBSA-Lackland), TX intends to solicit and award a sole-source, firm-fixed-price, five-year purchase order to Siemens Healthcare Diagnostics, Inc, under the authority of RFO 6.103-1(a). This requirement is for EMIT II Plus Amphetamines Assay testing kits for the Air Force Drug Testing Laboratory (AFDTL) at JBSA-Lackland, TX. This will be awarded as a Blanket Purchase Agreement (BPA) with a five (5) year ordering period. Through market research and the AFDTL experience with various testing kits, the EMIT II Plus Amphetamines Assay testing kits is essential to the Government's requirements as no other product can meet the agency's needs without unacceptable schedule delays and duplication of cost. Siemens Healthcare Diagnostics,

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for in-vitro diagnostic substance manufacturing with a set-aside for No Set Aside businesses in JBSA LACKLAND, TX. This set-aside designation means eligible businesses face reduced competition from larger firms.